Evaluation of sedation and analgesia in standing horses after administration of xylazine, butorphanol, and subanesthetic doses of ketamine.

The research article explores the effects of administering subanesthetic doses of ketamine, in addition to xylazine and butorphanol, on sedation and pain relief in horses. The researchers discovered that co-administration could enhance certain procedures and improve tolerance to stimuli, but might potentially exacerbate reactions to acute pain.

Methodology

• The study was designed as a prospective, randomized, controlled study with a sample group of 10 adult horses.
• Each horse was given multiple sessions of sedation using different combinations of drugs (xylazine, xylazine and butorphanol, xylazine with either of two dosages of ketamine, or xylazine and butorphanol with either of two dosages of ketamine).
• Variables such as the horse’s head height, behavior reactions to noise, response to inserting a dental float and a needle prick on the flank, reaction to algometer pressure on the scapula, and responses to bilateral carpal arthrocenteses were assessed.

Results

• The study revealed no significant variances among the different sedative treatments in terms of head height, response to noise, or reaction to arthrocenteses.
• It was easier to insert a dental float during treatment XBK2, while it was more challenging during treatments XK1 and XK2.
• The reaction to a needle prick on the flank was at its lowest during treatment XB, and at its highest during treatment XK2.
• Response to algometer pressure over the scapula was highest with treatment XBK2 and lowest with treatment X.

Conclusions

• The study concluded that administration of subanesthetic dosages of ketamine in combination with xylazine and butorphanol might improve certain procedures, such as a dental float insertion in horses, and increase tolerance to pressure stimulation.
• However, it might also worsen responses to acute pain such as that caused by a needle prick.
• The researchers recommend further evaluation to determine whether subanesthetic dosages of ketamine might be beneficial in performing certain clinical procedures in horses.